ABCG2 and cancer: In addition, the different inhibitory effects of QB1561 in parent and drug-resistant cancer cells, as shown in Figure 2, which were much less significant than AF and these tested chemotherapeutics, suggested that it might be a weak substrate of ABCB1 and ABCG2.